• 14943 Citations
  • 46 h-Index
1988 …2020
If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 1982 Taipei Medical College, M.D.

Research Interests

  • Hepatitis
  • Hepatocellular Carcinoma
  • Virology

Experience

  • 1990/8~1993/7 Instructor of Medicine, Medical College, National Cheng Kung University (NCKU)
  • 1993/8~1996/7 Associate Professor, Medical College, National Cheng Kung University (NCKU)
  • 1996/8~present Professor of Medicine, Medical College, National Cheng Kung University (NCKU)
  • 1998/8~2000/7 Secretary of Medical Affairs, National Cheng Kung University Hospital (NCKUH)
  • 2000/8~2002/7 Director, Department of Clinical Medicine, National Cheng Kung University Hospital (NCKUH)
  • 2000/8~2004/7 Director, Institute of Molecular Medicine, Medical College, National Cheng Kung University (NCKU)
  • 2000/8~2004/7 Chief, Division of Gastroenterology, National Cheng Kung University Hospital (NCKUH)
  • 2003~present Director, Biotechnologic Center of Hepatology, Research and Services Headquarter of National Cheng Kung University
  • 2006~present Distinguished Professor of Internal Medicine, Medical College, NCKU
  • 2013/8~2017/7 Associate Director, Medical College, National Cheng Kung University Hospital (NCKUH)

Fingerprint Dive into the research topics where Ting-Tsung Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 35 Similar Profiles
Chronic Hepatitis B Medicine & Life Sciences
Hepatitis B e Antigens Medicine & Life Sciences
Hepatitis B virus Medicine & Life Sciences
Hepacivirus Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Virus Diseases Medicine & Life Sciences
Taiwan Medicine & Life Sciences
Hepatitis B Surface Antigens Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1995 2020

Research Output 1988 2019

Propensity Score
Hepatocellular Carcinoma
Survival
Liver
Liver Neoplasms

Fully galactosyl-fucosyl-bisected IgG 1 reduces anti-HBV efficacy and liver histological improvement

Ho, C. H., Chen, S-H., Tsai, H-W., Wu, I-C. & Chang, T-T., 2019 Mar 1, In : Antiviral Research. 163, p. 1-10 10 p.

Research output: Contribution to journalArticle

Hepatitis B virus
Immunoglobulin G
Liver
Hepatitis B e Antigens
Acetylglucosamine

Plasma proteome plus site-specific N-glycoprofiling for hepatobiliary carcinomas

Chang, T-T., Cheng, J. H., Tsai, H-W., Young, K-C., Hsieh, S-Y. & Ho, C. H., 2019 Jul 1, In : Journal of Pathology: Clinical Research. 5, 3, p. 199-212 14 p.

Research output: Contribution to journalArticle

Open Access
Proteome
Complement C3
Carcinoma
Hepatocellular Carcinoma
Cholangiocarcinoma
3 Citations (Scopus)
Satellite Viruses
Viruses
Hepatitis B virus
Hepatocellular Carcinoma
Nucleotides
1 Citation (Scopus)
Chronic Hepatitis B
Hepatitis B Surface Antigens
Hepatitis B e Antigens
Therapeutics
entecavir

Thesis

The clinical and virological characteristics of HCV genotype 6 in Southern Taiwan

Author: 彥程, 邱., 2017 Sep 4

Supervisor: Chang, T. (Supervisor)

Student thesis: Master's Thesis

The clinicopathological significance of progesterone receptor membrane component 1 (PGRMC1) in hepatocellular carcinoma

Author: 弘文, 蔡., 2018 Jun 28

Supervisor: Chang, T. (Supervisor)

Student thesis: Doctoral Thesis

慢性B型肝炎病人肝指數異常與單核?酸多態性之相關性研究

Author: 宏智, 邱., 2017 Feb 3

Supervisor: Chang, T. (Supervisor)

Student thesis: Master's Thesis

探討microRNA-29a於人體肝癌中所扮演的角色:統合分析研究

Author: 姿璿, 吳., 2018 Oct 26

Supervisor: Chang, T. (Supervisor)

Student thesis: Master's Thesis